No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 4db5A, 1.0000, 0.00, 1.000, 120, 120, CRYSTAL STRUCTURE OF RABBIT GITRL
2, 3b93A, 0.9426, 1.24, 0.708, 123, 120, CRYSTAL STRUCTURE OF HUMAN GITRL
3, 4e4sE, 0.9196, 1.25, 0.784, 119, 116, CRYSTAL STRUCTURE OF PIKA GITRL
4, 4e4sC, 0.9129, 0.74, 0.805, 114, 113, CRYSTAL STRUCTURE OF PIKA GITRL
5, 4e4sB, 0.9090, 1.23, 0.765, 115, 115, CRYSTAL STRUCTURE OF PIKA GITRL
6, 4e4sF, 0.9062, 0.83, 0.814, 114, 113, CRYSTAL STRUCTURE OF PIKA GITRL
7, 2r30A, 0.9040, 1.39, 0.704, 116, 115, CRYSTAL STRUCTURE OF HUMAN GITRL MUTANT
8, 2q1mA, 0.9035, 1.39, 0.704, 116, 115, CRYSTAL STRUCTURE OF HUMAN GITRL
9, 4e4sA, 0.9027, 0.77, 0.804, 113, 112, CRYSTAL STRUCTURE OF PIKA GITRL
10, 4e4sD, 0.8931, 0.79, 0.811, 112, 111, CRYSTAL STRUCTURE OF PIKA GITRL
11, 2r32A, 0.8866, 0.90, 0.755, 140, 110, CRYSTAL STRUCTURE OF HUMAN GITRL VARIANT
12, 3b94D, 0.8778, 1.08, 0.727, 112, 110, CRYSTAL STRUCTURE OF HUMAN GITRL
13, 3b94B, 0.8747, 1.38, 0.705, 113, 112, CRYSTAL STRUCTURE OF HUMAN GITRL
14, 3b9iB, 0.8656, 1.59, 0.530, 123, 115, CRYSTAL STRUCTURE OF MOUSE GITRL AT 2.5 A.
15, 2qdnB, 0.8637, 1.61, 0.530, 123, 115, CRYSTAL STRUCTURE OF MOUSE GITRL
16, 2q8oB, 0.8622, 1.62, 0.539, 125, 115, CRYSTAL STRUCTURE OF MOUSE GITR LIGAND DIMER
17, 3b9iA, 0.8494, 1.81, 0.530, 123, 115, CRYSTAL STRUCTURE OF MOUSE GITRL AT 2.5 A.
18, 2qdnA, 0.8470, 1.82, 0.530, 123, 115, CRYSTAL STRUCTURE OF MOUSE GITRL
19, 3fc0A, 0.8461, 1.85, 0.530, 123, 115, 1.8 A CRYSTAL STRUCTURE OF MURINE GITR LIGAND DIMER EXPRESSED IN DROSOPHILA MELANOGASTER S2 CELLS
20, 2q8oA, 0.8452, 1.86, 0.539, 125, 115, CRYSTAL STRUCTURE OF MOUSE GITR LIGAND DIMER
21, 3fc0B, 0.8330, 1.71, 0.536, 119, 112, 1.8 A CRYSTAL STRUCTURE OF MURINE GITR LIGAND DIMER EXPRESSED IN DROSOPHILA MELANOGASTER S2 CELLS
22, 4g4fA, 0.8224, 1.87, 0.618, 114, 110, CRYSTAL STRUCTURE OF GITRL FROM BUSHBABY
23, 3b93B, 0.7983, 0.88, 0.737, 100, 99, CRYSTAL STRUCTURE OF HUMAN GITRL
24, 1rj7B, 0.7896, 2.39, 0.157, 144, 115, CRYSTAL STRUCTURE OF EDA-A1
25, 3b94A, 0.7888, 1.20, 0.740, 102, 100, CRYSTAL STRUCTURE OF HUMAN GITRL
26, 1rj7K, 0.7880, 2.56, 0.164, 145, 116, CRYSTAL STRUCTURE OF EDA-A1
27, 1rj7D, 0.7873, 2.42, 0.157, 144, 115, CRYSTAL STRUCTURE OF EDA-A1
28, 1rj7F, 0.7865, 2.43, 0.157, 144, 115, CRYSTAL STRUCTURE OF EDA-A1
29, 1rj7G, 0.7863, 2.48, 0.157, 144, 115, CRYSTAL STRUCTURE OF EDA-A1
30, 1rj7A, 0.7858, 2.45, 0.157, 144, 115, CRYSTAL STRUCTURE OF EDA-A1
31, 1rj7M, 0.7848, 2.45, 0.157, 144, 115, CRYSTAL STRUCTURE OF EDA-A1
32, 1rj7L, 0.7842, 2.41, 0.157, 145, 115, CRYSTAL STRUCTURE OF EDA-A1
33, 1rj7E, 0.7833, 2.44, 0.157, 149, 115, CRYSTAL STRUCTURE OF EDA-A1
34, 1rj7J, 0.7828, 2.43, 0.157, 143, 115, CRYSTAL STRUCTURE OF EDA-A1
35, 1rj8G, 0.7784, 2.34, 0.161, 140, 112, THE CRYSTAL STRUCTURE OF TNF FAMILY MEMBER EDA-A2
36, 1rj7I, 0.7781, 2.44, 0.158, 143, 114, CRYSTAL STRUCTURE OF EDA-A1
37, 1rj8B, 0.7780, 2.27, 0.161, 140, 112, THE CRYSTAL STRUCTURE OF TNF FAMILY MEMBER EDA-A2
38, 1rj8F, 0.7771, 2.30, 0.161, 140, 112, THE CRYSTAL STRUCTURE OF TNF FAMILY MEMBER EDA-A2
39, 1rj8E, 0.7770, 2.30, 0.161, 140, 112, THE CRYSTAL STRUCTURE OF TNF FAMILY MEMBER EDA-A2
40, 1rj8D, 0.7760, 2.32, 0.161, 140, 112, THE CRYSTAL STRUCTURE OF TNF FAMILY MEMBER EDA-A2
41, 1rj8A, 0.7757, 2.38, 0.152, 140, 112, THE CRYSTAL STRUCTURE OF TNF FAMILY MEMBER EDA-A2
42, 1rj7H, 0.7745, 2.42, 0.159, 142, 113, CRYSTAL STRUCTURE OF EDA-A1
43, 4giqA, 0.7679, 2.33, 0.152, 155, 112, CRYSTAL STRUCTURE OF MOUSE RANK BOUND TO RANKL
44, 3me2A, 0.7673, 2.34, 0.152, 156, 112, CRYSTAL STRUCTURE OF MOUSE RANKL-RANK COMPLEX
45, 1wckA, 0.7669, 2.07, 0.083, 136, 109, CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF BCLA THE MAJOR ANTIGEN OF THE EXOSPORIUM OF THE BACILLUS ANTHRACIS SPORE.
46, 1jtzX, 0.7666, 2.31, 0.152, 155, 112, CRYSTAL STRUCTURE OF TRANCE/RANKL CYTOKINE.
47, 1i9rB, 0.7666, 2.31, 0.243, 143, 111, STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY
48, 2z5wA, 0.7665, 2.06, 0.083, 136, 109, TBCLA A RECOMBINANT SPORE SURFACE PROTEIN FROM BACILLUS ANTHRACIS
49, 1i9rA, 0.7663, 2.32, 0.243, 143, 111, STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY
50, 1i9rC, 0.7661, 2.31, 0.243, 143, 111, STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY
51, 1s55A, 0.7655, 2.32, 0.152, 156, 112, MOUSE RANKL STRUCTURE AT 1.9A RESOLUTION
52, 1s55C, 0.7651, 2.36, 0.152, 156, 112, MOUSE RANKL STRUCTURE AT 1.9A RESOLUTION
53, 1jtzZ, 0.7650, 2.34, 0.152, 155, 112, CRYSTAL STRUCTURE OF TRANCE/RANKL CYTOKINE.
54, 3ab0A, 0.7644, 2.10, 0.083, 136, 109, CRYSTAL STRUCTURE OF COMPLEX OF THE BACILLUS ANTHRACIS MAJOR SPORE SURFACE PROTEIN BCLA WITH SCFV ANTIBODY FRAGMENT
55, 5kc6B, 0.7635, 2.41, 0.097, 144, 113, CRYSTAL STRUCTURE OF CBLN1 (VAL55-GLY58 DELETION MUTANT)
56, 3twiC, 0.7634, 2.08, 0.083, 136, 109, VARIABLE LYMPHOCYTE RECEPTOR RECOGNITION OF THE IMMUNODOMINANT GLYCOPROTEIN OF BACILLUS ANTHRACIS SPORES
57, 1jtzY, 0.7634, 2.34, 0.152, 155, 112, CRYSTAL STRUCTURE OF TRANCE/RANKL CYTOKINE.
58, 3ab0D, 0.7623, 2.11, 0.083, 136, 109, CRYSTAL STRUCTURE OF COMPLEX OF THE BACILLUS ANTHRACIS MAJOR SPORE SURFACE PROTEIN BCLA WITH SCFV ANTIBODY FRAGMENT
59, 3twiA, 0.7618, 2.10, 0.083, 136, 109, VARIABLE LYMPHOCYTE RECEPTOR RECOGNITION OF THE IMMUNODOMINANT GLYCOPROTEIN OF BACILLUS ANTHRACIS SPORES
60, 3twiB, 0.7608, 2.12, 0.083, 136, 109, VARIABLE LYMPHOCYTE RECEPTOR RECOGNITION OF THE IMMUNODOMINANT GLYCOPROTEIN OF BACILLUS ANTHRACIS SPORES
61, 3b94C, 0.7606, 2.00, 0.717, 100, 99, CRYSTAL STRUCTURE OF HUMAN GITRL
62, 1s55B, 0.7605, 2.47, 0.152, 156, 112, MOUSE RANKL STRUCTURE AT 1.9A RESOLUTION
63, 5yoyA, 0.7600, 2.42, 0.216, 154, 111, CRYSTAL STRUCTURE OF THE HUMAN TUMOR NECROSIS FACTOR IN COMPLEX WITH GOLIMUMAB FV 
64, 3qbqC, 0.7597, 2.44, 0.153, 155, 111, CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAINS OF MOUSE RANK-RANKL COMPLEX
65, 5bnqA, 0.7593, 2.43, 0.143, 156, 112, CRYSTAL STRUCTURE OF HRANKL-MRANK COMPLEX
66, 3tyjA, 0.7589, 2.08, 0.083, 136, 108, BACILLUS COLLAGEN-LIKE PROTEIN OF ANTHRACIS P159S MUTANT
67, 5yoyC, 0.7586, 2.38, 0.216, 154, 111, CRYSTAL STRUCTURE OF THE HUMAN TUMOR NECROSIS FACTOR IN COMPLEX WITH GOLIMUMAB FV 
68, 2r6qA, 0.7583, 2.08, 0.083, 138, 108, CRYSTAL STRUCTURE OF BCLA-ISLAND CONSTRUCT
69, 5yoyB, 0.7582, 2.39, 0.216, 154, 111, CRYSTAL STRUCTURE OF THE HUMAN TUMOR NECROSIS FACTOR IN COMPLEX WITH GOLIMUMAB FV 
70, 5kwrA, 0.7574, 2.30, 0.099, 139, 111, CRYSTAL STRUCTURE OF RAT CEREBELLIN-1
71, 3qbqA, 0.7573, 2.44, 0.153, 155, 111, CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAINS OF MOUSE RANK-RANKL COMPLEX
72, 1osgC, 0.7557, 2.23, 0.176, 144, 108, COMPLEX BETWEEN BAFF AND A BR3 DERIVED PEPTIDE PRESENTED IN A BETA-HAIRPIN SCAFFOLD
73, 5kc6A, 0.7554, 2.41, 0.098, 137, 112, CRYSTAL STRUCTURE OF CBLN1 (VAL55-GLY58 DELETION MUTANT)
74, 1osgE, 0.7554, 2.24, 0.167, 144, 108, COMPLEX BETWEEN BAFF AND A BR3 DERIVED PEPTIDE PRESENTED IN A BETA-HAIRPIN SCAFFOLD
75, 1kxgE, 0.7553, 2.30, 0.167, 144, 108, THE 2.0 ANG RESOLUTION STRUCTURE OF BLYS B LYMPHOCYTE STIMULATOR.
76, 4qqoA, 0.7549, 2.33, 0.091, 130, 110, CRYSTAL STRUCTURE OF C1QL3 MUTANT D205A
77, 3v56C, 0.7549, 2.25, 0.176, 144, 108, RE-REFINEMENT OF PDB ENTRY 1OSG - COMPLEX BETWEEN BAFF AND A BR3 DERIVED PEPTIDE PRESENTED IN A BETA-HAIRPIN SCAFFOLD - REVEALS AN ADDITONAL COPY OF THE PEPTIDE.
78, 3v56E, 0.7546, 2.25, 0.176, 144, 108, RE-REFINEMENT OF PDB ENTRY 1OSG - COMPLEX BETWEEN BAFF AND A BR3 DERIVED PEPTIDE PRESENTED IN A BETA-HAIRPIN SCAFFOLD - REVEALS AN ADDITONAL COPY OF THE PEPTIDE.
79, 1osgB, 0.7545, 2.22, 0.167, 144, 108, COMPLEX BETWEEN BAFF AND A BR3 DERIVED PEPTIDE PRESENTED IN A BETA-HAIRPIN SCAFFOLD
80, 1kxgC, 0.7545, 2.25, 0.167, 144, 108, THE 2.0 ANG RESOLUTION STRUCTURE OF BLYS B LYMPHOCYTE STIMULATOR.
81, 5l19A, 0.7543, 2.43, 0.167, 150, 108, CRYSTAL STRUCTURE OF A HUMAN FASL MUTANT
82, 5yoyL, 0.7542, 2.38, 0.218, 153, 110, CRYSTAL STRUCTURE OF THE HUMAN TUMOR NECROSIS FACTOR IN COMPLEX WITH GOLIMUMAB FV 
83, 3v56B, 0.7542, 2.24, 0.167, 144, 108, RE-REFINEMENT OF PDB ENTRY 1OSG - COMPLEX BETWEEN BAFF AND A BR3 DERIVED PEPTIDE PRESENTED IN A BETA-HAIRPIN SCAFFOLD - REVEALS AN ADDITONAL COPY OF THE PEPTIDE.
84, 1osgD, 0.7530, 2.25, 0.167, 144, 108, COMPLEX BETWEEN BAFF AND A BR3 DERIVED PEPTIDE PRESENTED IN A BETA-HAIRPIN SCAFFOLD
85, 1osgA, 0.7530, 2.23, 0.176, 144, 108, COMPLEX BETWEEN BAFF AND A BR3 DERIVED PEPTIDE PRESENTED IN A BETA-HAIRPIN SCAFFOLD
86, 1osgF, 0.7529, 2.24, 0.176, 144, 108, COMPLEX BETWEEN BAFF AND A BR3 DERIVED PEPTIDE PRESENTED IN A BETA-HAIRPIN SCAFFOLD
87, 3v56A, 0.7528, 2.25, 0.176, 144, 108, RE-REFINEMENT OF PDB ENTRY 1OSG - COMPLEX BETWEEN BAFF AND A BR3 DERIVED PEPTIDE PRESENTED IN A BETA-HAIRPIN SCAFFOLD - REVEALS AN ADDITONAL COPY OF THE PEPTIDE.
88, 3urfA, 0.7527, 2.53, 0.143, 156, 112, HUMAN RANKL/OPG COMPLEX
89, 3v56F, 0.7525, 2.25, 0.176, 144, 108, RE-REFINEMENT OF PDB ENTRY 1OSG - COMPLEX BETWEEN BAFF AND A BR3 DERIVED PEPTIDE PRESENTED IN A BETA-HAIRPIN SCAFFOLD - REVEALS AN ADDITONAL COPY OF THE PEPTIDE.
90, 5yoyJ, 0.7523, 2.40, 0.218, 153, 110, CRYSTAL STRUCTURE OF THE HUMAN TUMOR NECROSIS FACTOR IN COMPLEX WITH GOLIMUMAB FV 
91, 5kc5A, 0.7522, 2.29, 0.100, 137, 110, CRYSTAL STRUCTURE OF THE CBLN1 C1Q DOMAIN TRIMER
92, 5l36A, 0.7521, 2.47, 0.167, 138, 108, CRYSTAL STRUCTURE OF A HUMAN FASL MUTANT IN COMPLEX WITH HUMAN DCR3
93, 1kd7L, 0.7521, 2.25, 0.167, 144, 108, CRYSTAL STRUCTURE OF AN EXTRACELLULAR DOMAIN FRAGMENT OF HUMAN BAFF
94, 1kd7M, 0.7520, 2.25, 0.167, 144, 108, CRYSTAL STRUCTURE OF AN EXTRACELLULAR DOMAIN FRAGMENT OF HUMAN BAFF
95, 1kd7B, 0.7520, 2.25, 0.167, 144, 108, CRYSTAL STRUCTURE OF AN EXTRACELLULAR DOMAIN FRAGMENT OF HUMAN BAFF
96, 3v56D, 0.7519, 2.26, 0.167, 144, 108, RE-REFINEMENT OF PDB ENTRY 1OSG - COMPLEX BETWEEN BAFF AND A BR3 DERIVED PEPTIDE PRESENTED IN A BETA-HAIRPIN SCAFFOLD - REVEALS AN ADDITONAL COPY OF THE PEPTIDE.
97, 1kd7C, 0.7519, 2.25, 0.167, 144, 108, CRYSTAL STRUCTURE OF AN EXTRACELLULAR DOMAIN FRAGMENT OF HUMAN BAFF
98, 1kd7A, 0.7519, 2.25, 0.167, 144, 108, CRYSTAL STRUCTURE OF AN EXTRACELLULAR DOMAIN FRAGMENT OF HUMAN BAFF
99, 1kd7K, 0.7518, 2.25, 0.167, 144, 108, CRYSTAL STRUCTURE OF AN EXTRACELLULAR DOMAIN FRAGMENT OF HUMAN BAFF
100, 1alyA, 0.7517, 2.41, 0.216, 146, 111, CRYSTAL STRUCTURE OF HUMAN CD40 LIGAND
101, 5m2iB, 0.7516, 2.38, 0.220, 148, 109, STRUCTURE OF HUMAN TUMOR NECROSIS FACTOR (TNF) IN COMPLEX WITH THE LLAMA VHH1
102, 5kcaA, 0.7516, 2.46, 0.098, 807, 112, CRYSTAL STRUCTURE OF THE CBLN1 C1Q DOMAIN TRIMER IN COMPLEX WITH THE AMINO-TERMINAL DOMAIN (ATD) OF IGLUR DELTA-2 (GLUD2)
103, 1kxgB, 0.7516, 2.33, 0.167, 144, 108, THE 2.0 ANG RESOLUTION STRUCTURE OF BLYS B LYMPHOCYTE STIMULATOR.
104, 6fxnL, 0.7515, 2.25, 0.167, 144, 108, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
105, 6erxL, 0.7514, 2.25, 0.167, 144, 108, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
106, 3lkjB, 0.7510, 2.11, 0.243, 132, 107, SMALL MOLECULE INHIBITION OF THE TNF FAMILY CYOKINE CD40 LIGAND THROUGH A SUBUNIT FRACTURE MECHANISM
107, 5m2iE, 0.7508, 2.37, 0.220, 146, 109, STRUCTURE OF HUMAN TUMOR NECROSIS FACTOR (TNF) IN COMPLEX WITH THE LLAMA VHH1
108, 6erxB, 0.7507, 2.26, 0.167, 144, 108, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
109, 4qqlC, 0.7507, 2.44, 0.091, 131, 110, CRYSTAL STRUCTURE OF C1QL3 IN P1 SPACE GROUP
110, 1kxgD, 0.7507, 2.31, 0.167, 144, 108, THE 2.0 ANG RESOLUTION STRUCTURE OF BLYS B LYMPHOCYTE STIMULATOR.
111, 6fxnB, 0.7506, 2.26, 0.167, 144, 108, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
112, 6erxJ, 0.7506, 2.25, 0.167, 144, 108, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
113, 6erxC, 0.7506, 2.25, 0.167, 144, 108, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
114, 6fxnC, 0.7503, 2.25, 0.167, 144, 108, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
115, 6erxK, 0.7503, 2.25, 0.167, 144, 108, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
116, 4oulA, 0.7501, 2.31, 0.155, 132, 110, CRYSTAL STRUCTURE OF HUMAN CAPRIN-2 C1Q DOMAIN
117, 5yoyK, 0.7500, 2.42, 0.218, 153, 110, CRYSTAL STRUCTURE OF THE HUMAN TUMOR NECROSIS FACTOR IN COMPLEX WITH GOLIMUMAB FV 
118, 5y9jA, 0.7499, 2.26, 0.167, 144, 108, BAFF IN COMPLEX WITH BELIMUMAB
119, 4qqlI, 0.7499, 2.48, 0.091, 131, 110, CRYSTAL STRUCTURE OF C1QL3 IN P1 SPACE GROUP
120, 6fxnK, 0.7498, 2.25, 0.167, 144, 108, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
121, 6fxnJ, 0.7498, 2.26, 0.167, 144, 108, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
122, 4v46JA, 0.7496, 2.26, 0.167, 144, 108, 
123, 4v46DA, 0.7495, 2.27, 0.167, 144, 108, 
124, 5m2iC, 0.7494, 2.39, 0.220, 148, 109, STRUCTURE OF HUMAN TUMOR NECROSIS FACTOR (TNF) IN COMPLEX WITH THE LLAMA VHH1
125, 4v46XA, 0.7494, 2.27, 0.167, 144, 108, 
126, 4v46TA, 0.7494, 2.27, 0.167, 144, 108, 
127, 4v46T, 0.7494, 2.27, 0.167, 144, 108, 
128, 4v46P, 0.7494, 2.27, 0.167, 144, 108, 
129, 4v46OA, 0.7494, 2.27, 0.167, 144, 108, 
130, 4v46K, 0.7494, 2.27, 0.167, 144, 108, 
131, 4v46GB, 0.7494, 2.27, 0.167, 144, 108, 
132, 4v46F, 0.7494, 2.27, 0.167, 144, 108, 
133, 4v46BA, 0.7494, 2.27, 0.167, 144, 108, 
134, 1oqdH, 0.7494, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF STALL-1 AND BCMA
135, 4v46ZA, 0.7493, 2.27, 0.167, 144, 108, 
136, 4v46Z, 0.7493, 2.27, 0.167, 144, 108, 
137, 4v46X, 0.7493, 2.27, 0.167, 144, 108, 
138, 4v46VA, 0.7493, 2.27, 0.167, 144, 108, 
139, 4v46V, 0.7493, 2.27, 0.167, 144, 108, 
140, 4v46R, 0.7493, 2.27, 0.167, 144, 108, 
141, 4v46Q, 0.7493, 2.27, 0.167, 144, 108, 
142, 4v46NA, 0.7493, 2.27, 0.167, 144, 108, 
143, 4v46N, 0.7493, 2.27, 0.167, 144, 108, 
144, 4v46MA, 0.7493, 2.27, 0.167, 144, 108, 
145, 4v46KA, 0.7493, 2.27, 0.167, 144, 108, 
146, 4v46IA, 0.7493, 2.27, 0.167, 144, 108, 
147, 4v46FB, 0.7493, 2.27, 0.167, 144, 108, 
148, 4v46FA, 0.7493, 2.27, 0.167, 144, 108, 
149, 4v46DB, 0.7493, 2.27, 0.167, 144, 108, 
150, 4v46D, 0.7493, 2.27, 0.167, 144, 108, 
151, 4v46CA, 0.7493, 2.27, 0.167, 144, 108, 
152, 4v46C, 0.7493, 2.27, 0.167, 144, 108, 
153, 4rsuA, 0.7493, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF THE LIGHT AND HVEM COMPLEX
154, 5m2iA, 0.7492, 2.27, 0.167, 144, 108, STRUCTURE OF HUMAN TUMOR NECROSIS FACTOR (TNF) IN COMPLEX WITH THE LLAMA VHH1
155, 4v46Y, 0.7492, 2.27, 0.167, 144, 108, 
156, 4v46SA, 0.7492, 2.27, 0.167, 144, 108, 
157, 4v46RA, 0.7492, 2.27, 0.167, 144, 108, 
158, 4v46QA, 0.7492, 2.27, 0.167, 144, 108, 
159, 4v46PA, 0.7492, 2.27, 0.167, 144, 108, 
160, 4v46M, 0.7492, 2.27, 0.167, 144, 108, 
161, 4v46J, 0.7492, 2.27, 0.167, 144, 108, 
162, 4v46G, 0.7492, 2.27, 0.167, 144, 108, 
163, 4v46EB, 0.7492, 2.27, 0.167, 144, 108, 
164, 4v46BB, 0.7492, 2.27, 0.167, 144, 108, 
165, 4v46AB, 0.7492, 2.27, 0.167, 144, 108, 
166, 4v46AA, 0.7492, 2.27, 0.167, 144, 108, 
167, 5m2iF, 0.7491, 2.27, 0.167, 144, 108, STRUCTURE OF HUMAN TUMOR NECROSIS FACTOR (TNF) IN COMPLEX WITH THE LLAMA VHH1
168, 4v46YA, 0.7491, 2.09, 0.157, 149, 108, 
169, 4v46WA, 0.7491, 2.40, 0.220, 148, 109, 
170, 4v46W, 0.7491, 2.27, 0.167, 144, 108, 
171, 4v46UA, 0.7491, 2.27, 0.167, 144, 108, 
172, 4v46U, 0.7491, 2.27, 0.167, 144, 108, 
173, 4v46O, 0.7491, 2.27, 0.167, 144, 108, 
174, 4v46LA, 0.7491, 2.27, 0.167, 144, 108, 
175, 4v46L, 0.7491, 2.27, 0.167, 144, 108, 
176, 4v46I, 0.7491, 2.27, 0.167, 144, 108, 
177, 4v46HB, 0.7491, 2.27, 0.167, 144, 108, 
178, 4v46H, 0.7491, 2.27, 0.167, 144, 108, 
179, 4v46GA, 0.7491, 2.26, 0.167, 144, 108, 
180, 4v46EA, 0.7491, 2.27, 0.167, 144, 108, 
181, 4v46E, 0.7491, 2.27, 0.167, 144, 108, 
182, 4v46CB, 0.7491, 2.27, 0.167, 144, 108, 
183, 4v46B, 0.7491, 2.27, 0.167, 144, 108, 
184, 4v46S, 0.7490, 2.27, 0.167, 144, 108, 
185, 4v46HA, 0.7490, 2.27, 0.167, 144, 108, 
186, 4v46A, 0.7490, 2.27, 0.167, 144, 108, 
187, 1oqeH, 0.7490, 2.40, 0.220, 148, 109, CRYSTAL STRUCTURE OF STALL-1 WITH BAFF-R
188, 5kc6C, 0.7489, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF CBLN1 (VAL55-GLY58 DELETION MUTANT)
189, 1oqdJ, 0.7489, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF STALL-1 AND BCMA
190, 1oqdD, 0.7489, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF STALL-1 AND BCMA
191, 1oqdA, 0.7489, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF STALL-1 AND BCMA
192, 4d7yA, 0.7488, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF MOUSE C1QL1 GLOBULAR DOMAIN
193, 1oqdE, 0.7488, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF STALL-1 AND BCMA
194, 1oqdC, 0.7488, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF STALL-1 AND BCMA
195, 1oqdB, 0.7488, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF STALL-1 AND BCMA
196, 4e4dX, 0.7487, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF MOUSE RANKL-OPG COMPLEX
197, 3lkjC, 0.7486, 2.27, 0.167, 144, 108, SMALL MOLECULE INHIBITION OF THE TNF FAMILY CYOKINE CD40 LIGAND THROUGH A SUBUNIT FRACTURE MECHANISM
198, 1oqdG, 0.7486, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF STALL-1 AND BCMA
199, 1oqdF, 0.7486, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF STALL-1 AND BCMA
200, 5m2mA, 0.7485, 2.27, 0.167, 144, 108, COMPLEX BETWEEN HUMAN TNF ALPHA AND LLAMA VHH3
201, 5h4cB, 0.7485, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF CBLN4
202, 4rsuG, 0.7485, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF THE LIGHT AND HVEM COMPLEX
203, 1oqeD, 0.7484, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF STALL-1 WITH BAFF-R
204, 4kggA, 0.7483, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF LIGHT MUTANT2 AND DCR3 COMPLEX
205, 1oqeE, 0.7483, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF STALL-1 WITH BAFF-R
206, 1oqdI, 0.7483, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF STALL-1 AND BCMA
207, 4rsuI, 0.7482, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF THE LIGHT AND HVEM COMPLEX
208, 1kxgF, 0.7482, 2.27, 0.167, 144, 108, THE 2.0 ANG RESOLUTION STRUCTURE OF BLYS B LYMPHOCYTE STIMULATOR.
209, 5m2iD, 0.7481, 2.27, 0.167, 144, 108, STRUCTURE OF HUMAN TUMOR NECROSIS FACTOR (TNF) IN COMPLEX WITH THE LLAMA VHH1
210, 4qqlF, 0.7481, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF C1QL3 IN P1 SPACE GROUP
211, 6erxA, 0.7480, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
212, 1oqeJ, 0.7480, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF STALL-1 WITH BAFF-R
213, 1oqeF, 0.7480, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF STALL-1 WITH BAFF-R
214, 1oqeC, 0.7480, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF STALL-1 WITH BAFF-R
215, 1oqeB, 0.7480, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF STALL-1 WITH BAFF-R
216, 1oqeA, 0.7480, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF STALL-1 WITH BAFF-R
217, 4qqlA, 0.7479, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF C1QL3 IN P1 SPACE GROUP
218, 1oqeG, 0.7479, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF STALL-1 WITH BAFF-R
219, 1kxgA, 0.7479, 2.27, 0.167, 144, 108, THE 2.0 ANG RESOLUTION STRUCTURE OF BLYS B LYMPHOCYTE STIMULATOR.
220, 1jh5G, 0.7479, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF STALL-1 OF TNF FAMILY LIGAND
221, 5m2mI, 0.7478, 2.28, 0.167, 144, 108, COMPLEX BETWEEN HUMAN TNF ALPHA AND LLAMA VHH3
222, 4qqlB, 0.7478, 2.40, 0.099, 136, 111, CRYSTAL STRUCTURE OF C1QL3 IN P1 SPACE GROUP
223, 1jh5J, 0.7478, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF STALL-1 OF TNF FAMILY LIGAND
224, 1jh5I, 0.7478, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF STALL-1 OF TNF FAMILY LIGAND
225, 1jh5H, 0.7478, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF STALL-1 OF TNF FAMILY LIGAND
226, 1jh5F, 0.7478, 2.42, 0.118, 131, 110, CRYSTAL STRUCTURE OF STALL-1 OF TNF FAMILY LIGAND
227, 1jh5D, 0.7478, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF STALL-1 OF TNF FAMILY LIGAND
228, 1jh5C, 0.7478, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF STALL-1 OF TNF FAMILY LIGAND
229, 1jh5B, 0.7478, 2.27, 0.167, 144, 108, CRYSTAL STRUCTURE OF STALL-1 OF TNF FAMILY LIGAND
230, 1jh5A, 0.7478, 2.66, 0.153, 154, 111, CRYSTAL STRUCTURE OF STALL-1 OF TNF FAMILY LIGAND
231, 4qqlG, 0.7477, 2.37, 0.231, 129, 108, CRYSTAL STRUCTURE OF C1QL3 IN P1 SPACE GROUP
232, 1oqeI, 0.7477, 2.28, 0.167, 144, 108, CRYSTAL STRUCTURE OF STALL-1 WITH BAFF-R
233, 1jh5E, 0.7477, 2.28, 0.167, 144, 108, CRYSTAL STRUCTURE OF STALL-1 OF TNF FAMILY LIGAND
234, 4msvA, 0.7476, 2.40, 0.220, 150, 109, CRYSTAL STRUCTURE OF FASL AND DCR3 COMPLEX
235, 5m2mB, 0.7475, 2.25, 0.101, 135, 109, COMPLEX BETWEEN HUMAN TNF ALPHA AND LLAMA VHH3
236, 5m2mC, 0.7474, 2.10, 0.157, 150, 108, COMPLEX BETWEEN HUMAN TNF ALPHA AND LLAMA VHH3
237, 4qqlH, 0.7473, 2.28, 0.167, 144, 108, CRYSTAL STRUCTURE OF C1QL3 IN P1 SPACE GROUP
238, 6fxnA, 0.7472, 2.24, 0.167, 141, 108, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
239, 5m2mG, 0.7471, 2.28, 0.167, 144, 108, COMPLEX BETWEEN HUMAN TNF ALPHA AND LLAMA VHH3
240, 4qqlD, 0.7470, 2.28, 0.167, 144, 108, CRYSTAL STRUCTURE OF C1QL3 IN P1 SPACE GROUP
241, 4qq2A, 0.7470, 2.15, 0.167, 147, 108, CRYSTAL STRUCTURE OF C1QL1
242, 2tnfC, 0.7468, 2.32, 0.167, 144, 108, 1.4 A RESOLUTION STRUCTURE OF MOUSE TUMOR NECROSIS FACTOR TOWARDS MODULATION OF ITS SELCTIVITY AND TRIMERISATION
243, 4en0B, 0.7467, 2.43, 0.220, 148, 109, CRYSTAL STRUCTURE OF LIGHT
244, 4kggB, 0.7465, 2.49, 0.091, 130, 110, CRYSTAL STRUCTURE OF LIGHT MUTANT2 AND DCR3 COMPLEX
245, 5tswC, 0.7464, 2.29, 0.176, 144, 108, HIGH RESOLUTION CRYSTAL STRUCTURE OF A HUMAN TNF-ALPHA MUTANT
246, 4qqlE, 0.7464, 2.28, 0.167, 144, 108, CRYSTAL STRUCTURE OF C1QL3 IN P1 SPACE GROUP
247, 5wuxF, 0.7463, 2.28, 0.167, 144, 108, TNFALPHA-CERTOLIZUMAB FAB
248, 2e7aA, 0.7463, 2.28, 0.167, 144, 108, TNF RECEPTOR SUBTYPE ONE-SELECTIVE TNF MUTANT WITH ANTAGONISTIC ACTIVITY
249, 4qq2B, 0.7462, 2.28, 0.167, 144, 108, CRYSTAL STRUCTURE OF C1QL1
250, 2zjcB, 0.7460, 2.28, 0.167, 144, 108, TNFR1 SELECTVE TNF MUTANT; R1-6
251, 4zchB, 0.7459, 2.49, 0.091, 130, 110, SINGLE-CHAIN HUMAN APRIL-BAFF-BAFF HETEROTRIMER
252, 4n90C, 0.7458, 2.28, 0.167, 144, 108, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF TRAIL DR5 AND FAB FRAGMENT FROM A DR5 AGONIST ANTIBODY
253, 3l9jT, 0.7454, 2.28, 0.167, 144, 108, SELECTION OF A NOVEL HIGHLY SPECIFIC TNFALPHA ANTAGONIST: INSIGHT FROM THE CRYSTAL STRUCTURE OF THE ANTAGONIST-TNFALPHA COMPLEX
254, 4oulC, 0.7453, 2.29, 0.167, 144, 108, CRYSTAL STRUCTURE OF HUMAN CAPRIN-2 C1Q DOMAIN
255, 2zjcA, 0.7452, 2.42, 0.220, 150, 109, TNFR1 SELECTVE TNF MUTANT; R1-6
256, 2rjlA, 0.7452, 2.46, 0.091, 130, 110, CRYSTAL STRUCTURE OF HUMAN TL1A EXTRACELLULAR DOMAIN C95S/C135S MUTANT
257, 4oulE, 0.7451, 2.29, 0.167, 144, 108, CRYSTAL STRUCTURE OF HUMAN CAPRIN-2 C1Q DOMAIN
258, 1iqaA, 0.7451, 2.29, 0.167, 144, 108, CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MOUSE RANK LIGAND
259, 3lkjA, 0.7449, 2.29, 0.167, 144, 108, SMALL MOLECULE INHIBITION OF THE TNF FAMILY CYOKINE CD40 LIGAND THROUGH A SUBUNIT FRACTURE MECHANISM
260, 3alqC, 0.7449, 2.29, 0.167, 144, 108, CRYSTAL STRUCTURE OF TNF-TNFR2 COMPLEX
261, 2re9B, 0.7449, 2.29, 0.167, 144, 108, CRYSTAL STRUCTURE OF TL1A AT 2.1 A
262, 1c3hD, 0.7449, 2.29, 0.167, 144, 108, ACRP30 CALCIUM COMPLEX
263, 5tswD, 0.7447, 2.29, 0.167, 144, 108, HIGH RESOLUTION CRYSTAL STRUCTURE OF A HUMAN TNF-ALPHA MUTANT
264, 2tnfB, 0.7447, 2.29, 0.167, 144, 108, 1.4 A RESOLUTION STRUCTURE OF MOUSE TUMOR NECROSIS FACTOR TOWARDS MODULATION OF ITS SELCTIVITY AND TRIMERISATION
265, 4oulF, 0.7446, 2.46, 0.091, 130, 110, CRYSTAL STRUCTURE OF HUMAN CAPRIN-2 C1Q DOMAIN
266, 4qqhA, 0.7444, 2.29, 0.167, 144, 108, CRYSTAL STRUCTURE OF C1QL3 IN SPACE GROUP H32
267, 4qqpA, 0.7443, 2.29, 0.167, 144, 108, CRYSTAL STRUCTURE OF C1QL3 MUTANT D207A
268, 2rjkA, 0.7443, 2.50, 0.167, 139, 108, CRYSTAL STRUCTURE OF HUMAN TL1A EXTRACELLULAR DOMAIN C95S MUTANT
269, 3alqB, 0.7442, 2.45, 0.220, 151, 109, CRYSTAL STRUCTURE OF TNF-TNFR2 COMPLEX
270, 4oumA, 0.7441, 2.46, 0.220, 150, 109, CRYSTAL STRUCTURE OF HUMAN CAPRIN-2 C1Q DOMAIN
271, 3it8H, 0.7441, 2.46, 0.091, 130, 110, CRYSTAL STRUCTURE OF TNF ALPHA COMPLEXED WITH A POXVIRUS MHC-RELATED TNF BINDING PROTEIN
272, 5tswF, 0.7440, 2.29, 0.167, 144, 108, HIGH RESOLUTION CRYSTAL STRUCTURE OF A HUMAN TNF-ALPHA MUTANT
273, 4oulD, 0.7440, 2.45, 0.220, 150, 109, CRYSTAL STRUCTURE OF HUMAN CAPRIN-2 C1Q DOMAIN
274, 4kgqB, 0.7440, 2.50, 0.091, 130, 110, CRYSTAL STRUCTURE OF A HUMAN LIGHT LOOP MUTANT IN COMPLEX WITH DCR3
275, 1o91B, 0.7440, 2.46, 0.118, 131, 110, CRYSTAL STRUCTURE OF A COLLAGEN VIII NC1 DOMAIN TRIMER
276, 3it8G, 0.7439, 2.37, 0.174, 148, 109, CRYSTAL STRUCTURE OF TNF ALPHA COMPLEXED WITH A POXVIRUS MHC-RELATED TNF BINDING PROTEIN
277, 3it8A, 0.7439, 2.28, 0.157, 143, 108, CRYSTAL STRUCTURE OF TNF ALPHA COMPLEXED WITH A POXVIRUS MHC-RELATED TNF BINDING PROTEIN
278, 2re9A, 0.7439, 2.14, 0.159, 139, 107, CRYSTAL STRUCTURE OF TL1A AT 2.1 A
279, 1du3K, 0.7439, 2.45, 0.211, 149, 109, CRYSTAL STRUCTURE OF TRAIL-SDR5
280, 4tsvA, 0.7438, 2.49, 0.091, 130, 110, HIGH RESOLUTION CRYSTAL STRUCTURE OF A HUMAN TNF-ALPHA MUTANT
281, 3it8I, 0.7438, 2.45, 0.220, 141, 109, CRYSTAL STRUCTURE OF TNF ALPHA COMPLEXED WITH A POXVIRUS MHC-RELATED TNF BINDING PROTEIN
282, 3it8C, 0.7438, 2.43, 0.211, 150, 109, CRYSTAL STRUCTURE OF TNF ALPHA COMPLEXED WITH A POXVIRUS MHC-RELATED TNF BINDING PROTEIN
283, 3it8B, 0.7438, 2.43, 0.118, 131, 110, CRYSTAL STRUCTURE OF TNF ALPHA COMPLEXED WITH A POXVIRUS MHC-RELATED TNF BINDING PROTEIN
284, 3alqD, 0.7438, 2.53, 0.220, 151, 109, CRYSTAL STRUCTURE OF TNF-TNFR2 COMPLEX
285, 5h48A, 0.7437, 2.80, 0.153, 419, 111, CRYSTAL STRUCTURE OF CBLN1
286, 2tnfA, 0.7436, 2.52, 0.165, 154, 109, 1.4 A RESOLUTION STRUCTURE OF MOUSE TUMOR NECROSIS FACTOR TOWARDS MODULATION OF ITS SELCTIVITY AND TRIMERISATION
287, 2e7aC, 0.7436, 2.46, 0.220, 149, 109, TNF RECEPTOR SUBTYPE ONE-SELECTIVE TNF MUTANT WITH ANTAGONISTIC ACTIVITY
288, 5tswE, 0.7434, 2.32, 0.156, 131, 109, HIGH RESOLUTION CRYSTAL STRUCTURE OF A HUMAN TNF-ALPHA MUTANT
289, 5kc7D, 0.7434, 2.43, 0.220, 142, 109, CRYSTAL STRUCTURE OF CBLN1 (VAL55-GLY58 DELETION MUTANT)
290, 5kc7C, 0.7434, 2.23, 0.206, 141, 107, CRYSTAL STRUCTURE OF CBLN1 (VAL55-GLY58 DELETION MUTANT)
291, 5kc7B, 0.7434, 2.32, 0.156, 130, 109, CRYSTAL STRUCTURE OF CBLN1 (VAL55-GLY58 DELETION MUTANT)
292, 5kc7A, 0.7434, 2.45, 0.155, 153, 110, CRYSTAL STRUCTURE OF CBLN1 (VAL55-GLY58 DELETION MUTANT)
293, 4oulB, 0.7434, 2.36, 0.241, 133, 108, CRYSTAL STRUCTURE OF HUMAN CAPRIN-2 C1Q DOMAIN
294, 1c3hF, 0.7434, 2.51, 0.211, 141, 109, ACRP30 CALCIUM COMPLEX
295, 1c3hE, 0.7434, 2.32, 0.196, 164, 107, ACRP30 CALCIUM COMPLEX
296, 5m2jA, 0.7432, 2.50, 0.127, 137, 110, COMPLEX BETWEEN HUMAN TNF ALPHA AND LLAMA VHH2
297, 4kgqA, 0.7432, 2.45, 0.211, 149, 109, CRYSTAL STRUCTURE OF A HUMAN LIGHT LOOP MUTANT IN COMPLEX WITH DCR3
298, 5h4cC, 0.7431, 2.42, 0.174, 148, 109, CRYSTAL STRUCTURE OF CBLN4
299, 1a8mA, 0.7431, 2.30, 0.156, 132, 109, TUMOR NECROSIS FACTOR ALPHA R31D MUTANT
300, 3alqA, 0.7430, 2.47, 0.091, 130, 110, CRYSTAL STRUCTURE OF TNF-TNFR2 COMPLEX
301, 1du3E, 0.7430, 2.47, 0.091, 130, 110, CRYSTAL STRUCTURE OF TRAIL-SDR5
302, 4rsuH, 0.7429, 2.25, 0.206, 141, 107, CRYSTAL STRUCTURE OF THE LIGHT AND HVEM COMPLEX
303, 3alqE, 0.7429, 2.50, 0.211, 141, 109, CRYSTAL STRUCTURE OF TNF-TNFR2 COMPLEX
304, 1a8mB, 0.7429, 2.33, 0.156, 132, 109, TUMOR NECROSIS FACTOR ALPHA R31D MUTANT
305, 2re9C, 0.7428, 2.45, 0.229, 152, 109, CRYSTAL STRUCTURE OF TL1A AT 2.1 A
306, 2e7aB, 0.7428, 2.44, 0.211, 149, 109, TNF RECEPTOR SUBTYPE ONE-SELECTIVE TNF MUTANT WITH ANTAGONISTIC ACTIVITY
307, 4zchA, 0.7426, 2.31, 0.156, 132, 109, SINGLE-CHAIN HUMAN APRIL-BAFF-BAFF HETEROTRIMER
308, 5cirB, 0.7425, 2.18, 0.159, 139, 107, CRYSTAL STRUCTURE OF DEATH RECEPTOR 4 (DR4; TNFFRSF10A) BOUND TO TRAIL (TNFSF10)
309, 3k51A, 0.7425, 2.41, 0.111, 131, 108, CRYSTAL STRUCTURE OF DCR3-TL1A COMPLEX
310, 4j6gB, 0.7423, 2.45, 0.229, 152, 109, CRYSTAL STRUCTURE OF LIGHT AND DCR3 COMPLEX
311, 5m2mM, 0.7421, 2.45, 0.229, 152, 109, COMPLEX BETWEEN HUMAN TNF ALPHA AND LLAMA VHH3
312, 2o0oA, 0.7421, 2.31, 0.196, 164, 107, CRYSTAL STRUCTURE OF TL1A
313, 1o91C, 0.7419, 2.48, 0.165, 152, 109, CRYSTAL STRUCTURE OF A COLLAGEN VIII NC1 DOMAIN TRIMER
314, 5tswB, 0.7418, 2.53, 0.211, 148, 109, HIGH RESOLUTION CRYSTAL STRUCTURE OF A HUMAN TNF-ALPHA MUTANT
315, 2qe3A, 0.7418, 2.45, 0.229, 152, 109, CRYSTAL STRUCTURE OF HUMAN TL1A EXTRACELLULAR DOMAIN
316, 5cirD, 0.7417, 2.45, 0.229, 152, 109, CRYSTAL STRUCTURE OF DEATH RECEPTOR 4 (DR4; TNFFRSF10A) BOUND TO TRAIL (TNFSF10)
317, 3mi8A, 0.7417, 2.45, 0.229, 152, 109, THE STRUCTURE OF TL1A-DCR3 COMPLEX
318, 4j6gA, 0.7416, 2.52, 0.211, 141, 109, CRYSTAL STRUCTURE OF LIGHT AND DCR3 COMPLEX
319, 4mxwY, 0.7413, 2.30, 0.101, 136, 109, STRUCTURE OF HETEROTRIMERIC LYMPHOTOXIN LTA1B2 BOUND TO LYMPHOTOXIN BETA RECEPTOR LTBR AND ANTI-LTA FAB
320, 4ousA, 0.7411, 2.49, 0.174, 148, 109, CRYSTAL STRUCTURE OF ZEBRAFISH CAPRIN-2 C1Q DOMAIN
321, 1iqaB, 0.7411, 2.46, 0.211, 143, 109, CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MOUSE RANK LIGAND
322, 1dg6A, 0.7411, 2.44, 0.211, 149, 109, CRYSTAL STRUCTURE OF APO2L/TRAIL
323, 1gr3A, 0.7410, 2.40, 0.100, 135, 110, STRUCTURE OF THE HUMAN COLLAGEN X NC1 TRIMER
324, 5uuiA, 0.7409, 2.40, 0.100, 135, 110, CRYSTAL STRUCTURE OF SPIN-LABELED T77C TNFA
325, 5tswA, 0.7409, 2.40, 0.100, 135, 110, HIGH RESOLUTION CRYSTAL STRUCTURE OF A HUMAN TNF-ALPHA MUTANT
326, 1tnfB, 0.7409, 2.40, 0.100, 135, 110, THE STRUCTURE OF TUMOR NECROSIS FACTOR-ALPHA AT 2.6 ANGSTROMS RESOLUTION. IMPLICATIONS FOR RECEPTOR BINDING
327, 1o91A, 0.7409, 2.32, 0.156, 132, 109, CRYSTAL STRUCTURE OF A COLLAGEN VIII NC1 DOMAIN TRIMER
328, 5mu8u, 0.7408, 2.44, 0.136, 137, 110, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
329, 2az5B, 0.7408, 2.60, 0.126, 137, 111, CRYSTAL STRUCTURE OF TNF-ALPHA WITH A SMALL MOLECULE INHIBITOR
330, 1du3F, 0.7408, 2.48, 0.220, 139, 109, CRYSTAL STRUCTURE OF TRAIL-SDR5
331, 5mu8e, 0.7407, 2.19, 0.159, 139, 107, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
332, 4n90B, 0.7405, 2.30, 0.101, 132, 109, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF TRAIL DR5 AND FAB FRAGMENT FROM A DR5 AGONIST ANTIBODY
333, 4g3yC, 0.7405, 2.49, 0.220, 152, 109, CRYSTAL STRUCTURE OF TNF-ALPHA IN COMPLEX WITH INFLIXIMAB FAB FRAGMENT
334, 3alqF, 0.7405, 2.50, 0.211, 141, 109, CRYSTAL STRUCTURE OF TNF-TNFR2 COMPLEX
335, 1iqaC, 0.7405, 2.49, 0.165, 152, 109, CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MOUSE RANK LIGAND
336, 1du3L, 0.7405, 2.20, 0.157, 150, 108, CRYSTAL STRUCTURE OF TRAIL-SDR5
337, 5mu8a, 0.7404, 2.51, 0.211, 141, 109, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
338, 4douA, 0.7404, 2.50, 0.220, 152, 109, CRYSTAL STRUCTURE OF A SINGLE-CHAIN TRIMER OF HUMAN ADIPONECTIN GLOBULAR DOMAIN
339, 5h49C, 0.7402, 2.32, 0.196, 164, 107, CRYSTAL STRUCTURE OF CBLN1
340, 3qd6A, 0.7402, 2.47, 0.211, 142, 109, CRYSTAL STRUCTURE OF THE CD40 AND CD154 (CD40L) COMPLEX
341, 2tunE, 0.7402, 2.81, 0.171, 422, 111, CONFORMATIONAL CHANGES IN THE (ALA-84-VAL) MUTANT OF TUMOR NECROSIS FACTOR
342, 5wuxG, 0.7401, 2.55, 0.165, 151, 109, TNFALPHA-CERTOLIZUMAB FAB
343, 5mu8c, 0.7401, 2.19, 0.198, 143, 106, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
344, 3qd6F, 0.7401, 2.21, 0.159, 139, 107, CRYSTAL STRUCTURE OF THE CD40 AND CD154 (CD40L) COMPLEX
345, 5mu8s, 0.7400, 2.47, 0.222, 148, 108, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
346, 5h4bA, 0.7399, 2.33, 0.196, 153, 107, CRYSTAL STRUCTURE OF CBLN4
347, 3qd6E, 0.7399, 2.42, 0.111, 131, 108, CRYSTAL STRUCTURE OF THE CD40 AND CD154 (CD40L) COMPLEX
348, 1tnfC, 0.7399, 2.50, 0.211, 149, 109, THE STRUCTURE OF TUMOR NECROSIS FACTOR-ALPHA AT 2.6 ANGSTROMS RESOLUTION. IMPLICATIONS FOR RECEPTOR BINDING
349, 1du3J, 0.7399, 2.20, 0.208, 140, 106, CRYSTAL STRUCTURE OF TRAIL-SDR5
350, 5mu8q, 0.7398, 2.57, 0.165, 150, 109, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
351, 3qd6C, 0.7398, 2.18, 0.198, 144, 106, CRYSTAL STRUCTURE OF THE CD40 AND CD154 (CD40L) COMPLEX
352, 2o0oC, 0.7396, 2.22, 0.159, 139, 107, CRYSTAL STRUCTURE OF TL1A
353, 3qd6D, 0.7395, 2.85, 0.159, 131, 113, CRYSTAL STRUCTURE OF THE CD40 AND CD154 (CD40L) COMPLEX
354, 2az5D, 0.7395, 2.34, 0.119, 132, 109, CRYSTAL STRUCTURE OF TNF-ALPHA WITH A SMALL MOLECULE INHIBITOR
355, 4qq2C, 0.7394, 2.49, 0.155, 153, 110, CRYSTAL STRUCTURE OF C1QL1
356, 2zpxB, 0.7394, 2.45, 0.167, 149, 108, TNF RECEPTOR SUBTYPE ONE-SELECTIVE TNF MUTANT WITH ANTAGONISTIC ACTIVITY; R1ANTTNF-T8
357, 1du3D, 0.7394, 2.54, 0.101, 132, 109, CRYSTAL STRUCTURE OF TRAIL-SDR5
358, 4n90A, 0.7392, 2.21, 0.226, 134, 106, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF TRAIL DR5 AND FAB FRAGMENT FROM A DR5 AGONIST ANTIBODY
359, 3qd6B, 0.7392, 2.49, 0.211, 149, 109, CRYSTAL STRUCTURE OF THE CD40 AND CD154 (CD40L) COMPLEX
360, 2zpxC, 0.7390, 2.52, 0.229, 152, 109, TNF RECEPTOR SUBTYPE ONE-SELECTIVE TNF MUTANT WITH ANTAGONISTIC ACTIVITY; R1ANTTNF-T8
361, 1tnfA, 0.7390, 2.44, 0.111, 131, 108, THE STRUCTURE OF TUMOR NECROSIS FACTOR-ALPHA AT 2.6 ANGSTROMS RESOLUTION. IMPLICATIONS FOR RECEPTOR BINDING
362, 2zpxA, 0.7388, 2.55, 0.220, 145, 109, TNF RECEPTOR SUBTYPE ONE-SELECTIVE TNF MUTANT WITH ANTAGONISTIC ACTIVITY; R1ANTTNF-T8
363, 2o0oB, 0.7388, 2.58, 0.220, 140, 109, CRYSTAL STRUCTURE OF TL1A
364, 5mu8I, 0.7387, 2.53, 0.174, 152, 109, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
365, 4mxvD, 0.7386, 2.56, 0.220, 149, 109, STRUCTURE OF LYMPHOTOXIN ALPHA BOUND TO ANTI-LTA FAB
366, 1d4vB, 0.7386, 2.56, 0.165, 155, 109, CRYSTAL STRUCTURE OF TRAIL-DR5 COMPLEX
367, 2tunC, 0.7384, 2.58, 0.220, 148, 109, CONFORMATIONAL CHANGES IN THE (ALA-84-VAL) MUTANT OF TUMOR NECROSIS FACTOR
368, 2zjcC, 0.7383, 2.55, 0.211, 141, 109, TNFR1 SELECTVE TNF MUTANT; R1-6
369, 1c28A, 0.7382, 2.51, 0.155, 153, 110, THE CRYSTAL STRUCTURE OF A COMPLMENT-1Q FAMILY PROTEIN SUGGESTS AN EVOLUTIONARY LINK TO TUMOR NECROSIS FACTOR
370, 4twtC, 0.7379, 2.54, 0.165, 152, 109, HUMAN TNFA DIMER IN COMPLEX WITH THE SEMI-SYNTHETIC BICYCLIC PEPTIDE M21
371, 3wd5A, 0.7379, 2.54, 0.220, 149, 109, CRYSTAL STRUCTURE OF TNFALPHA IN COMPLEX WITH ADALIMUMAB FAB FRAGMENT
372, 5mu8Q, 0.7378, 2.48, 0.136, 399, 110, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
373, 5mu8f, 0.7377, 2.38, 0.100, 127, 110, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
374, 5mu8M, 0.7375, 2.04, 0.248, 135, 105, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
375, 5mu8O, 0.7374, 2.51, 0.229, 151, 109, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
376, 1tnrA, 0.7374, 2.47, 0.220, 141, 109, CRYSTAL STRUCTURE OF THE SOLUBLE HUMAN 55 KD TNF RECEPTOR- HUMAN TNF-BETA COMPLEX: IMPLICATIONS FOR TNF RECEPTOR ACTIVATION
377, 5mu8K, 0.7372, 2.56, 0.220, 145, 109, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
378, 5mu8U, 0.7371, 2.04, 0.238, 135, 105, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
379, 4nn0B, 0.7371, 2.54, 0.220, 149, 109, CRYSTAL STRUCTURE OF THE C1QTNF5 GLOBULAR DOMAIN IN SPACE GROUP P63
380, 4mxvB, 0.7371, 2.34, 0.101, 136, 109, STRUCTURE OF LYMPHOTOXIN ALPHA BOUND TO ANTI-LTA FAB
381, 4en0C, 0.7370, 2.07, 0.248, 135, 105, CRYSTAL STRUCTURE OF LIGHT
382, 5mu8g, 0.7369, 2.55, 0.229, 152, 109, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
383, 4twtA, 0.7369, 2.52, 0.165, 152, 109, HUMAN TNFA DIMER IN COMPLEX WITH THE SEMI-SYNTHETIC BICYCLIC PEPTIDE M21
384, 5mu8m, 0.7368, 2.46, 0.222, 149, 108, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
385, 5mu8G, 0.7368, 2.06, 0.238, 135, 105, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
386, 5mu8S, 0.7365, 2.34, 0.196, 152, 107, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
387, 5mu8P, 0.7364, 2.07, 0.238, 135, 105, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
388, 4qpyC, 0.7362, 2.59, 0.220, 141, 109, CRYSTAL STRUCTURE OF C1QL2
389, 2tunD, 0.7361, 2.42, 0.119, 129, 109, CONFORMATIONAL CHANGES IN THE (ALA-84-VAL) MUTANT OF TUMOR NECROSIS FACTOR
390, 5mu8W, 0.7358, 2.40, 0.213, 142, 108, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
391, 5mu8o, 0.7358, 2.55, 0.165, 152, 109, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
392, 5mu8k, 0.7358, 2.51, 0.165, 155, 109, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
393, 5mu8i, 0.7357, 2.07, 0.238, 135, 105, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
394, 5mu8Y, 0.7353, 2.40, 0.213, 142, 108, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
395, 4rsuB, 0.7353, 2.54, 0.229, 152, 109, CRYSTAL STRUCTURE OF THE LIGHT AND HVEM COMPLEX
396, 4nn0A, 0.7350, 2.39, 0.213, 142, 108, CRYSTAL STRUCTURE OF THE C1QTNF5 GLOBULAR DOMAIN IN SPACE GROUP P63
397, 5mu8H, 0.7349, 2.35, 0.196, 153, 107, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
398, 5cirA, 0.7346, 2.57, 0.220, 141, 109, CRYSTAL STRUCTURE OF DEATH RECEPTOR 4 (DR4; TNFFRSF10A) BOUND TO TRAIL (TNFSF10)
399, 4qpyB, 0.7345, 2.61, 0.119, 132, 109, CRYSTAL STRUCTURE OF C1QL2
400, 2tunF, 0.7345, 2.55, 0.156, 163, 109, CONFORMATIONAL CHANGES IN THE (ALA-84-VAL) MUTANT OF TUMOR NECROSIS FACTOR
401, 1d0gB, 0.7345, 2.50, 0.229, 151, 109, CRYSTAL STRUCTURE OF DEATH RECEPTOR 5 (DR5) BOUND TO APO2L/TRAIL
402, 4mxvA, 0.7344, 2.48, 0.220, 142, 109, STRUCTURE OF LYMPHOTOXIN ALPHA BOUND TO ANTI-LTA FAB
403, 1d0gA, 0.7340, 2.40, 0.139, 125, 108, CRYSTAL STRUCTURE OF DEATH RECEPTOR 5 (DR5) BOUND TO APO2L/TRAIL
404, 5mu8B, 0.7339, 2.60, 0.220, 143, 109, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
405, 4rsuC, 0.7338, 2.53, 0.220, 152, 109, CRYSTAL STRUCTURE OF THE LIGHT AND HVEM COMPLEX
406, 4qpyA, 0.7337, 2.59, 0.220, 149, 109, CRYSTAL STRUCTURE OF C1QL2
407, 1a8mC, 0.7337, 2.59, 0.220, 143, 109, TUMOR NECROSIS FACTOR ALPHA R31D MUTANT
408, 1d0gD, 0.7336, 2.55, 0.220, 149, 109, CRYSTAL STRUCTURE OF DEATH RECEPTOR 5 (DR5) BOUND TO APO2L/TRAIL
409, 5mu8w, 0.7334, 2.46, 0.222, 145, 108, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
410, 5mu8D, 0.7334, 2.46, 0.120, 144, 108, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
411, 5mu8n, 0.7333, 2.60, 0.220, 149, 109, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
412, 5mu8C, 0.7331, 2.60, 0.220, 149, 109, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
413, 5mu8v, 0.7330, 2.76, 0.098, 141, 112, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
414, 4f3jA, 0.7330, 2.52, 0.120, 137, 108, CRYSTAL STRUCTURE OF TRIMERIC GC1Q DOMAIN OF HUMAN C1QTNF5 ASSOCIATED WITH LATE-ONSET RETINAL MACULAR DEGENERATION
415, 2tunA, 0.7328, 2.60, 0.157, 144, 108, CONFORMATIONAL CHANGES IN THE (ALA-84-VAL) MUTANT OF TUMOR NECROSIS FACTOR
416, 5mu8r, 0.7324, 2.59, 0.220, 145, 109, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
417, 5mu8R, 0.7321, 2.50, 0.222, 150, 108, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
418, 4nn0C, 0.7320, 2.47, 0.222, 147, 108, CRYSTAL STRUCTURE OF THE C1QTNF5 GLOBULAR DOMAIN IN SPACE GROUP P63
419, 5mu8J, 0.7318, 2.60, 0.220, 149, 109, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
420, 5wuxE, 0.7314, 2.61, 0.220, 149, 109, TNFALPHA-CERTOLIZUMAB FAB
421, 5mu8V, 0.7314, 2.56, 0.220, 145, 109, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
422, 5h49A, 0.7310, 2.56, 0.109, 131, 110, CRYSTAL STRUCTURE OF CBLN1
423, 2jg8B, 0.7310, 2.54, 0.229, 151, 109, CRYSTALLOGRAPHIC STRUCTURE OF HUMAN C1Q GLOBULAR HEADS COMPLEXED TO PHOSPHATIDYL-SERINE
424, 5h4cA, 0.7307, 2.61, 0.220, 143, 109, CRYSTAL STRUCTURE OF CBLN4
425, 2jg9E, 0.7307, 2.46, 0.222, 147, 108, CRYSTALLOGRAPHIC STRUCTURE OF HUMAN C1Q GLOBULAR HEADS (P1)
426, 5mu8j, 0.7306, 2.47, 0.222, 142, 108, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
427, 5mu8b, 0.7306, 2.47, 0.222, 145, 108, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
428, 2jg9B, 0.7306, 2.63, 0.220, 149, 109, CRYSTALLOGRAPHIC STRUCTURE OF HUMAN C1Q GLOBULAR HEADS (P1)
429, 2wnvB, 0.7304, 2.19, 0.160, 142, 106, COMPLEX BETWEEN C1Q GLOBULAR HEADS AND DEOXYRIBOSE
430, 2jg8E, 0.7304, 2.63, 0.099, 137, 111, CRYSTALLOGRAPHIC STRUCTURE OF HUMAN C1Q GLOBULAR HEADS COMPLEXED TO PHOSPHATIDYL-SERINE
431, 2wnuE, 0.7302, 2.60, 0.220, 150, 109, COMPLEX BETWEEN C1Q GLOBULAR HEADS AND HEPARAN SULFATE
432, 5mu8X, 0.7298, 2.56, 0.167, 149, 108, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
433, 5mu8A, 0.7298, 2.54, 0.109, 134, 110, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
434, 1u5yA, 0.7298, 2.52, 0.229, 151, 109, CRYSTAL STRUCTURE OF MURINE APRIL PH 8.0
435, 2tunB, 0.7296, 2.62, 0.147, 151, 109, CONFORMATIONAL CHANGES IN THE (ALA-84-VAL) MUTANT OF TUMOR NECROSIS FACTOR
436, 2wnuB, 0.7295, 2.55, 0.120, 137, 108, COMPLEX BETWEEN C1Q GLOBULAR HEADS AND HEPARAN SULFATE
437, 5mu8F, 0.7293, 2.61, 0.147, 151, 109, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
438, 4twtB, 0.7291, 2.63, 0.220, 145, 109, HUMAN TNFA DIMER IN COMPLEX WITH THE SEMI-SYNTHETIC BICYCLIC PEPTIDE M21
439, 1pk6B, 0.7291, 2.11, 0.162, 138, 105, GLOBULAR HEAD OF THE COMPLEMENT SYSTEM PROTEIN C1Q
440, 2wnvE, 0.7290, 2.56, 0.109, 131, 110, COMPLEX BETWEEN C1Q GLOBULAR HEADS AND DEOXYRIBOSE
441, 2az5C, 0.7288, 2.39, 0.222, 152, 108, CRYSTAL STRUCTURE OF TNF-ALPHA WITH A SMALL MOLECULE INHIBITOR
442, 6fczB, 0.7285, 2.64, 0.165, 151, 109, MODEL OF GC1Q-FC COMPLEX BASED ON 7A EM MAP
443, 5mu8T, 0.7280, 2.54, 0.222, 145, 108, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
444, 5mu8L, 0.7280, 2.62, 0.220, 149, 109, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
445, 3k48A, 0.7280, 2.60, 0.220, 147, 109, CRYSTAL STRUCTURE OF APRIL BOUND TO A PEPTIDE
446, 1u5xA, 0.7279, 2.57, 0.220, 146, 109, CRYSTAL STRUCTURE OF MURINE APRIL AT PH 5.0
447, 2az5A, 0.7278, 2.61, 0.220, 144, 109, CRYSTAL STRUCTURE OF TNF-ALPHA WITH A SMALL MOLECULE INHIBITOR
448, 1xu2B, 0.7278, 2.56, 0.091, 143, 110, THE CRYSTAL STRUCTURE OF APRIL BOUND TO BCMA
449, 1xu1A, 0.7277, 2.59, 0.229, 151, 109, THE CRYSTAL STRUCTURE OF APRIL BOUND TO TACI
450, 1xu1B, 0.7267, 2.56, 0.220, 144, 109, THE CRYSTAL STRUCTURE OF APRIL BOUND TO TACI
451, 1xu2D, 0.7260, 2.61, 0.222, 138, 108, THE CRYSTAL STRUCTURE OF APRIL BOUND TO BCMA
452, 3b93C, 0.7259, 2.66, 0.099, 138, 111, CRYSTAL STRUCTURE OF HUMAN GITRL
453, 5mu8h, 0.7258, 2.56, 0.222, 138, 108, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
454, 1xu1D, 0.7256, 2.66, 0.220, 136, 109, THE CRYSTAL STRUCTURE OF APRIL BOUND TO TACI
455, 4mxwZ, 0.7251, 2.58, 0.222, 138, 108, STRUCTURE OF HETEROTRIMERIC LYMPHOTOXIN LTA1B2 BOUND TO LYMPHOTOXIN BETA RECEPTOR LTBR AND ANTI-LTA FAB
456, 1u5yB, 0.7250, 2.50, 0.100, 135, 110, CRYSTAL STRUCTURE OF MURINE APRIL PH 8.0
457, 5mu8t, 0.7244, 2.43, 0.131, 133, 107, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
458, 5mu8d, 0.7242, 2.43, 0.101, 134, 109, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
459, 4mxwB, 0.7240, 2.42, 0.131, 132, 107, STRUCTURE OF HETEROTRIMERIC LYMPHOTOXIN LTA1B2 BOUND TO LYMPHOTOXIN BETA RECEPTOR LTBR AND ANTI-LTA FAB
460, 5mu8N, 0.7239, 2.63, 0.220, 150, 109, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
461, 5mu8Z, 0.7237, 2.63, 0.220, 144, 109, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
462, 5h49B, 0.7237, 2.42, 0.131, 132, 107, CRYSTAL STRUCTURE OF CBLN1
463, 4mxwA, 0.7235, 2.43, 0.131, 131, 107, STRUCTURE OF HETEROTRIMERIC LYMPHOTOXIN LTA1B2 BOUND TO LYMPHOTOXIN BETA RECEPTOR LTBR AND ANTI-LTA FAB
464, 1u5zA, 0.7234, 2.42, 0.131, 132, 107, THE CRYSTAL STRUCTURE OF MURINE APRIL PH 8.5
465, 4en0A, 0.7220, 2.42, 0.131, 132, 107, CRYSTAL STRUCTURE OF LIGHT
466, 3k48B, 0.7219, 2.65, 0.220, 150, 109, CRYSTAL STRUCTURE OF APRIL BOUND TO A PEPTIDE
467, 4mxwX, 0.7218, 2.55, 0.222, 141, 108, STRUCTURE OF HETEROTRIMERIC LYMPHOTOXIN LTA1B2 BOUND TO LYMPHOTOXIN BETA RECEPTOR LTBR AND ANTI-LTA FAB
468, 5hzfA, 0.7214, 2.45, 0.168, 137, 107, SINGLE CHAIN RECOMBINANT GLOBULAR HEAD OF THE COMPLEMENT SYSTEM PROTEIN C1Q IN COMPLEX WITH MAGNESIUM
469, 5mu8l, 0.7211, 2.59, 0.229, 151, 109, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
470, 1xu2A, 0.7204, 2.43, 0.131, 132, 107, THE CRYSTAL STRUCTURE OF APRIL BOUND TO BCMA
471, 5hkjA, 0.7200, 2.65, 0.222, 140, 108, SINGLE CHAIN RECOMBINANT GLOBULAR HEAD OF THE COMPLEMENT SYSTEM PROTEIN C1Q
472, 5mu8p, 0.7196, 2.49, 0.224, 139, 107, HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525
473, 3k48D, 0.7196, 2.42, 0.131, 132, 107, CRYSTAL STRUCTURE OF APRIL BOUND TO A PEPTIDE
474, 1u5yD, 0.7195, 2.43, 0.131, 129, 107, CRYSTAL STRUCTURE OF MURINE APRIL PH 8.0
475, 4l92A, 0.7164, 2.61, 0.222, 129, 108, STRUCTURE OF THE RBP FROM LACTOCOCCAL PHAGE 1358 IN COMPLEX WITH 2 GLCNAC MOLECULES
476, 4rgaA, 0.7161, 2.45, 0.131, 132, 107, PHAGE 1358 RECEPTOR BINDING PROTEIN IN COMPLEX WITH THE TRISACCHARIDE GLCNAC-GALF-GLCOME
477, 4l99A, 0.7157, 2.64, 0.220, 146, 109, STRUCTURE OF THE RBP FROM LACTOCOCCAL PHAGE 1358 IN COMPLEX WITH GLYCEROL
478, 4rggB, 0.7155, 2.62, 0.220, 142, 109, STRUCTURE OF THE LACTOCOCCAL PHAGE 1358 RECEPTOR BINDING PROTEIN IN COMPLEX WITH GLCNAC-1P
479, 4mxwD, 0.7155, 2.49, 0.168, 137, 107, STRUCTURE OF HETEROTRIMERIC LYMPHOTOXIN LTA1B2 BOUND TO LYMPHOTOXIN BETA RECEPTOR LTBR AND ANTI-LTA FAB
480, 4l97A, 0.7155, 2.41, 0.168, 130, 107, STRUCTURE OF THE RBP OF LACTOCOCCAL PHAGE 1358 IN COMPLEX WITH GLUCOSE-1-PHOSPHATE
481, 6bwvB, 0.7153, 2.61, 0.222, 132, 108, CRYSTAL STRUCTURE OF THE 4-1BB/4-1BBL COMPLEX 
482, 4l9bA, 0.7153, 2.44, 0.168, 137, 107, STRUCTURE OF NATIVE RBP FROM LACTOCOCCAL PHAGE 1358 (CSI DERIVATIVE)
483, 4l92B, 0.7153, 2.42, 0.168, 137, 107, STRUCTURE OF THE RBP FROM LACTOCOCCAL PHAGE 1358 IN COMPLEX WITH 2 GLCNAC MOLECULES
484, 4rgaB, 0.7152, 2.44, 0.168, 137, 107, PHAGE 1358 RECEPTOR BINDING PROTEIN IN COMPLEX WITH THE TRISACCHARIDE GLCNAC-GALF-GLCOME
485, 4l99B, 0.7152, 2.45, 0.168, 137, 107, STRUCTURE OF THE RBP FROM LACTOCOCCAL PHAGE 1358 IN COMPLEX WITH GLYCEROL
486, 4l97B, 0.7151, 1.96, 0.716, 96, 95, STRUCTURE OF THE RBP OF LACTOCOCCAL PHAGE 1358 IN COMPLEX WITH GLUCOSE-1-PHOSPHATE
487, 4rggA, 0.7146, 2.65, 0.222, 137, 108, STRUCTURE OF THE LACTOCOCCAL PHAGE 1358 RECEPTOR BINDING PROTEIN IN COMPLEX WITH GLCNAC-1P
488, 1c3hB, 0.7139, 2.43, 0.168, 137, 107, ACRP30 CALCIUM COMPLEX
489, 1c3hA, 0.7138, 2.80, 0.164, 134, 110, ACRP30 CALCIUM COMPLEX
490, 4twtD, 0.7131, 2.40, 0.168, 137, 107, HUMAN TNFA DIMER IN COMPLEX WITH THE SEMI-SYNTHETIC BICYCLIC PEPTIDE M21
491, 1c3hC, 0.7131, 2.66, 0.222, 143, 108, ACRP30 CALCIUM COMPLEX
492, 2jg9F, 0.7119, 2.66, 0.222, 138, 108, CRYSTALLOGRAPHIC STRUCTURE OF HUMAN C1Q GLOBULAR HEADS (P1)
493, 2jg9C, 0.7118, 2.87, 0.164, 126, 110, CRYSTALLOGRAPHIC STRUCTURE OF HUMAN C1Q GLOBULAR HEADS (P1)
494, 4kg8A, 0.7117, 2.65, 0.222, 143, 108, CRYSTAL STRUCTURE OF LIGHT MUTANT
495, 6fczA, 0.7109, 2.69, 0.222, 143, 108, MODEL OF GC1Q-FC COMPLEX BASED ON 7A EM MAP
496, 2wnuD, 0.7109, 2.40, 0.103, 128, 107, COMPLEX BETWEEN C1Q GLOBULAR HEADS AND HEPARAN SULFATE
497, 2wnuC, 0.7109, 2.25, 0.125, 134, 104, COMPLEX BETWEEN C1Q GLOBULAR HEADS AND HEPARAN SULFATE
498, 1pk6A, 0.7109, 2.51, 0.168, 128, 107, GLOBULAR HEAD OF THE COMPLEMENT SYSTEM PROTEIN C1Q
499, 4ht1T, 0.7108, 2.59, 0.159, 145, 107, HUMAN TWEAK IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING ANTIBODY
500, 2jg8C, 0.7108, 2.52, 0.178, 137, 107, CRYSTALLOGRAPHIC STRUCTURE OF HUMAN C1Q GLOBULAR HEADS COMPLEXED TO PHOSPHATIDYL-SERINE
501, 6fczC, 0.7107, 2.27, 0.125, 134, 104, MODEL OF GC1Q-FC COMPLEX BASED ON 7A EM MAP
502, 1pk6C, 0.7107, 2.69, 0.147, 402, 109, GLOBULAR HEAD OF THE COMPLEMENT SYSTEM PROTEIN C1Q
503, 2wnuF, 0.7106, 2.69, 0.222, 143, 108, COMPLEX BETWEEN C1Q GLOBULAR HEADS AND HEPARAN SULFATE
504, 2wnuA, 0.7104, 2.50, 0.168, 137, 107, COMPLEX BETWEEN C1Q GLOBULAR HEADS AND HEPARAN SULFATE
505, 2jg8F, 0.7104, 2.66, 0.073, 402, 109, CRYSTALLOGRAPHIC STRUCTURE OF HUMAN C1Q GLOBULAR HEADS COMPLEXED TO PHOSPHATIDYL-SERINE
506, 2wnvF, 0.7102, 2.71, 0.222, 139, 108, COMPLEX BETWEEN C1Q GLOBULAR HEADS AND DEOXYRIBOSE
507, 2wnvC, 0.7102, 2.52, 0.178, 137, 107, COMPLEX BETWEEN C1Q GLOBULAR HEADS AND DEOXYRIBOSE
508, 2jg8A, 0.7101, 2.52, 0.168, 130, 107, CRYSTALLOGRAPHIC STRUCTURE OF HUMAN C1Q GLOBULAR HEADS COMPLEXED TO PHOSPHATIDYL-SERINE
509, 2jg9A, 0.7100, 2.89, 0.132, 390, 114, CRYSTALLOGRAPHIC STRUCTURE OF HUMAN C1Q GLOBULAR HEADS (P1)
510, 2jg9D, 0.7099, 2.89, 0.132, 390, 114, CRYSTALLOGRAPHIC STRUCTURE OF HUMAN C1Q GLOBULAR HEADS (P1)
511, 2jg8D, 0.7098, 2.89, 0.132, 390, 114, CRYSTALLOGRAPHIC STRUCTURE OF HUMAN C1Q GLOBULAR HEADS COMPLEXED TO PHOSPHATIDYL-SERINE
512, 6cprA, 0.7091, 2.90, 0.132, 390, 114, CRYSTAL STRUCTURE OF 4-1BBL/4-1BB COMPLEX IN C2 SPACE GROUP 
513, 6cprB, 0.7090, 2.88, 0.164, 135, 110, CRYSTAL STRUCTURE OF 4-1BBL/4-1BB COMPLEX IN C2 SPACE GROUP 
514, 6cu0F, 0.7089, 2.89, 0.132, 390, 114, CRYSTAL STRUCTURE OF 4-1BBL/4-1BB (C121S) COMPLEX IN P21 SPACE GROUP 
515, 2wnvD, 0.7089, 3.20, 0.143, 143, 112, COMPLEX BETWEEN C1Q GLOBULAR HEADS AND DEOXYRIBOSE
516, 2wnvA, 0.7079, 2.93, 0.132, 369, 114, COMPLEX BETWEEN C1Q GLOBULAR HEADS AND DEOXYRIBOSE
517, 6bwvA, 0.7071, 2.90, 0.132, 391, 114, CRYSTAL STRUCTURE OF THE 4-1BB/4-1BBL COMPLEX 
518, 1d2qB, 0.7070, 2.94, 0.132, 390, 114, CRYSTAL STRUCTURE OF HUMAN TRAIL
519, 1d2qA, 0.7070, 2.94, 0.132, 391, 114, CRYSTAL STRUCTURE OF HUMAN TRAIL
520, 6cu0C, 0.7060, 2.90, 0.132, 390, 114, CRYSTAL STRUCTURE OF 4-1BBL/4-1BB (C121S) COMPLEX IN P21 SPACE GROUP 
521, 6cprC, 0.7033, 2.88, 0.132, 390, 114, CRYSTAL STRUCTURE OF 4-1BBL/4-1BB COMPLEX IN C2 SPACE GROUP 
522, 6cu0D, 0.7023, 3.05, 0.155, 137, 110, CRYSTAL STRUCTURE OF 4-1BBL/4-1BB (C121S) COMPLEX IN P21 SPACE GROUP 
523, 2heyF, 0.7007, 3.04, 0.155, 137, 110, CRYSTAL STRUCTURE OF MURINE OX40L BOUND TO HUMAN OX40
524, 2hevF, 0.7007, 2.68, 0.226, 131, 106, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN OX40L AND OX40
525, 6cu0A, 0.7004, 3.05, 0.155, 137, 110, CRYSTAL STRUCTURE OF 4-1BBL/4-1BB (C121S) COMPLEX IN P21 SPACE GROUP 
526, 2heyG, 0.7000, 2.62, 0.150, 129, 107, CRYSTAL STRUCTURE OF MURINE OX40L BOUND TO HUMAN OX40
527, 4kg8B, 0.6999, 2.62, 0.150, 129, 107, CRYSTAL STRUCTURE OF LIGHT MUTANT
528, 6cu0E, 0.6981, 2.31, 0.157, 129, 102, CRYSTAL STRUCTURE OF 4-1BBL/4-1BB (C121S) COMPLEX IN P21 SPACE GROUP 
529, 6cu0B, 0.6978, 2.53, 0.075, 133, 107, CRYSTAL STRUCTURE OF 4-1BBL/4-1BB (C121S) COMPLEX IN P21 SPACE GROUP 
530, 5hbaC, 0.6917, 2.54, 0.075, 133, 107, GLOBULAR DOMAIN OF ZEBRAFISH COMPLEMENT 1QA PROTEIN
531, 5hbaB, 0.6916, 2.63, 0.150, 129, 107, GLOBULAR DOMAIN OF ZEBRAFISH COMPLEMENT 1QA PROTEIN
532, 5hbaA, 0.6903, 2.53, 0.075, 133, 107, GLOBULAR DOMAIN OF ZEBRAFISH COMPLEMENT 1QA PROTEIN
533, 2hewF, 0.6857, 2.92, 0.162, 131, 111, THE X-RAY CRYSTAL STRUCTURE OF MURINE OX40L
534, 4kg8C, 0.6856, 2.62, 0.150, 131, 107, CRYSTAL STRUCTURE OF LIGHT MUTANT
535, 6d3nA, 0.6765, 2.62, 0.150, 129, 107, CRYSTAL STRUCTURE OF H4-1BB LIGAND 
536, 1yq8A, 0.6643, 2.62, 0.150, 129, 107, PRD1 VERTEX PROTEIN P5
537, 2x29A, 0.6557, 2.63, 0.150, 129, 107, CRYSTAL STRUCTURE OF HUMAN4-1BB LIGAND ECTODOMAIN
538, 1yq5A, 0.6510, 2.54, 0.075, 133, 107, PRD1 VERTEX PROTEIN P5
539, 1yq6A, 0.6508, 2.63, 0.150, 129, 107, PRD1 VERTEX PROTEIN P5
540, 1yq5B, 0.6507, 2.63, 0.150, 129, 107, PRD1 VERTEX PROTEIN P5
541, 1yq6B, 0.6505, 2.63, 0.150, 129, 107, PRD1 VERTEX PROTEIN P5
542, 1yq6C, 0.6503, 2.54, 0.075, 133, 107, PRD1 VERTEX PROTEIN P5
543, 1c28B, 0.6366, 2.54, 0.075, 133, 107, THE CRYSTAL STRUCTURE OF A COMPLMENT-1Q FAMILY PROTEIN SUGGESTS AN EVOLUTIONARY LINK TO TUMOR NECROSIS FACTOR
544, 1c28C, 0.6315, 2.54, 0.075, 133, 107, THE CRYSTAL STRUCTURE OF A COMPLMENT-1Q FAMILY PROTEIN SUGGESTS AN EVOLUTIONARY LINK TO TUMOR NECROSIS FACTOR
545, 3gf6B, 0.6092, 2.54, 0.075, 133, 107, CRYSTAL STRUCTURE OF A BACTERIAL LIPOPROTEIN (BT_1233) FROM BACTEROIDES THETAIOTAOMICRON VPI-5482 AT 1.69 A RESOLUTION
546, 3gf6A, 0.6065, 3.16, 0.153, 152, 111, CRYSTAL STRUCTURE OF A BACTERIAL LIPOPROTEIN (BT_1233) FROM BACTEROIDES THETAIOTAOMICRON VPI-5482 AT 1.69 A RESOLUTION
547, 2wq4B, 0.6057, 3.17, 0.153, 151, 111, N-TERMINAL DOMAIN OF BC2L-C LECTIN FROM BURKHOLDERIA CENOCEPACIA
548, 2wq4A, 0.6037, 3.15, 0.144, 151, 111, N-TERMINAL DOMAIN OF BC2L-C LECTIN FROM BURKHOLDERIA CENOCEPACIA
549, 2wq4C, 0.5989, 2.55, 0.075, 133, 107, N-TERMINAL DOMAIN OF BC2L-C LECTIN FROM BURKHOLDERIA CENOCEPACIA
550, 4k6bA, 0.5901, 2.55, 0.075, 131, 107, ATOMIC STRUCTURE OF BACTERIOPHAGE HS1 TAIL NEEDLE KNOB
551, 4k6bC, 0.5892, 3.11, 0.145, 143, 110, ATOMIC STRUCTURE OF BACTERIOPHAGE HS1 TAIL NEEDLE KNOB
552, 3rwnC, 0.5888, 2.21, 0.176, 134, 102, ATOMIC STRUCTURE OF BACTERIOPHAGE SF6 TAIL NEEDLE KNOB
553, 3rwnB, 0.5883, 2.21, 0.176, 134, 102, ATOMIC STRUCTURE OF BACTERIOPHAGE SF6 TAIL NEEDLE KNOB
554, 4k6bB, 0.5875, 3.16, 0.144, 147, 111, ATOMIC STRUCTURE OF BACTERIOPHAGE HS1 TAIL NEEDLE KNOB
555, 3rwnA, 0.5858, 3.21, 0.155, 148, 110, ATOMIC STRUCTURE OF BACTERIOPHAGE SF6 TAIL NEEDLE KNOB
556, 5azxC, 0.5208, 3.15, 0.145, 147, 110, CRYSTAL STRUCTURE OF P24DELTA1 GOLD DOMAIN (NATIVE 1)
557, 5azxA, 0.5185, 2.90, 0.139, 135, 108, CRYSTAL STRUCTURE OF P24DELTA1 GOLD DOMAIN (NATIVE 1)
558, 5azyA, 0.5148, 2.87, 0.140, 126, 107, CRYSTAL STRUCTURE OF P24DELTA1 GOLD DOMAIN (NATIVE 2)
559, 5azxB, 0.5133, 3.17, 0.145, 152, 110, CRYSTAL STRUCTURE OF P24DELTA1 GOLD DOMAIN (NATIVE 1)
560, 5azyB, 0.5128, 2.78, 0.159, 134, 107, CRYSTAL STRUCTURE OF P24DELTA1 GOLD DOMAIN (NATIVE 2)
